Pages that link to "Q40433260"
Jump to navigation
Jump to search
The following pages link to Immunologic Mechanisms and Therapy in Multiple Sclerosis (Q40433260):
Displaying 50 items.
- Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis (Q24555084) (← links)
- Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis (Q24649574) (← links)
- The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases (Q24806216) (← links)
- Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects (Q28216546) (← links)
- A 21 point unifying hypothesis on the etiology and treatment of multiple sclerosis. (Q32062568) (← links)
- Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. (Q33665742) (← links)
- T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clones (Q33805885) (← links)
- The third function of the thymus. (Q33826591) (← links)
- Glia-T cell dialogue. (Q33943398) (← links)
- Regulatory T cells in the control of immune pathology. (Q34348983) (← links)
- Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis (Q34458130) (← links)
- The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis (Q35117424) (← links)
- A randomized pilot study of naturopathic medicine in multiple sclerosis (Q35157941) (← links)
- Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2 (Q35996437) (← links)
- Clinical experience with therapeutic AIDS vaccines (Q36198648) (← links)
- Therapeutic apheresis in neurology critical care (Q36215377) (← links)
- Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis (Q36366372) (← links)
- Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction (Q36368672) (← links)
- Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease (Q36377160) (← links)
- Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment (Q36385159) (← links)
- A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer (Q36392957) (← links)
- Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis (Q36401257) (← links)
- In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis (Q36401750) (← links)
- Multiple sclerosis therapy: an update on recently finished trials (Q37001453) (← links)
- Special regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier. (Q37043710) (← links)
- Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice (Q37176196) (← links)
- Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders (Q37193564) (← links)
- Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients (Q37356987) (← links)
- Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses. (Q40591610) (← links)
- Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells (Q40660123) (← links)
- Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system (Q40668935) (← links)
- Oral administration of myelin induces antigen-specific TGF-beta 1-secreting T cells in multiple sclerosis patients (Q41116621) (← links)
- Mechanisms of immune injury in multiple sclerosis (Q41157659) (← links)
- Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis (Q41228728) (← links)
- Immune recognition of influenza hemagglutinin as a viral and a neo-self-antigen (Q41710713) (← links)
- Cytokine-induced inflammation in the central nervous system revisited (Q41712468) (← links)
- Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain (Q41778413) (← links)
- Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone (Q43562148) (← links)
- Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions (Q43813961) (← links)
- Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection (Q45762639) (← links)
- Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides (Q46899500) (← links)
- Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study (Q46952197) (← links)
- Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis (Q46974506) (← links)
- Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis (Q48003302) (← links)
- Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis (Q48105762) (← links)
- Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis (Q48105784) (← links)
- Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis (Q48109136) (← links)
- Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid (Q48332401) (← links)
- Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing-remitting multiple sclerosis (Q48440316) (← links)
- The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up (Q48865810) (← links)